Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0291 Transporter Info | ||||
Gene Name | SLC35A5 | ||||
Transporter Name | Probable UDP-sugar transporter protein SLC35A5 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 5 TF(s) Regulating This DT |
|||||
ATF2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [1] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-2 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-2 (ATF2) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
ATF3 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SLC35A5 gene in glioblastoma multiforme condition | [2] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) has been reported to repress the transcription of SLC35A5 gene in glioblastoma multiforme condition, which leads to a decreased expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC35A5 gene | [3] | ||||
TF Protein Name |
Cyclic AMP-dependent transcription factor ATF-3 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Colon; Embryo; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
CEBPB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [1] | ||||
TF Protein Name |
CCAAT/enhancer-binding protein beta | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
CCAAT/enhancer-binding protein beta (CEBPB) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
CREB1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC35A5 gene in health condition | [4] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) has been reported to activate the transcription of SLC35A5 gene in health condition, which leads to an increased expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC35A5 gene | [5] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Embryo; Liver; Lung; Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
JUN |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [6] | ||||
TF Protein Name |
Transcription factor Jun | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor Jun (JUN) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
ARNTL |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [3] | ||||
TF Protein Name |
Basic helix-loop-helix ARNT-like protein 1 | Transcription Factor Info | ||||
Tissue |
Bone; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Basic helix-loop-helix ARNT-like protein 1 (ARNTL) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
CLOCK |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [5] | ||||
TF Protein Name |
Circadian locomoter output cycles protein kaput | Transcription Factor Info | ||||
Tissue |
Bone; Brain; Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Circadian locomoter output cycles protein kaput (CLOCK) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
MAX |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [6] | ||||
TF Protein Name |
Protein max | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Breast; Cervix; Embryo; Liver; Lung; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein max (MAX) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
VDR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC35A5 gene in health condition | [7] | ||||
TF Protein Name |
Vitamin D3 receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Vitamin D3 receptor (VDR) has been reported to bind to the transcription of SLC35A5 gene in health condition, which leads to an affected expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [5] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
GATA4 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC35A5 gene in gastric cancer condition | [8] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) has been reported to activate the transcription of SLC35A5 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC35A5 gene | [6] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Tissue |
Heart | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [3] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [5] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Pancreatic ductal; Stomach | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [1] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [1] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Tissue |
Mesenchymal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [3] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Pancreatic ductal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [1] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
EHF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [6] | ||||
TF Protein Name |
ETS homologous factor | Transcription Factor Info | ||||
Tissue |
Bronchus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
ETS homologous factor (EHF) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
ELK1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [9] | ||||
TF Protein Name |
ETS domain-containing protein Elk-1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
ETS domain-containing protein Elk-1 (ELK1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
ERG |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [5] | ||||
TF Protein Name |
Transcriptional regulator ERG | Transcription Factor Info | ||||
Tissue |
Aorta | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional regulator ERG (ERG) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
ETS1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC35A5 gene in T cell activation condition | [10] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Protein C-ets-1 (ETS1) has been reported to activate the transcription of SLC35A5 gene in T cell activation condition, which leads to an increased expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC35A5 gene | [6] | ||||
TF Protein Name |
Protein C-ets-1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Kidney; Lung; Prostate; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Protein C-ets-1 (ETS1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
FLI1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC35A5 gene in megakaryocytes condition | [11] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC35A5 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC35A5 gene | [3] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Umbilical cord blood; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [1] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Brain; Breast; Cervix; Liver; Lung; Mesenchymal; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [5] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC35A5 gene in APL condition | [12] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) has been reported to bind to the transcription of SLC35A5 gene in acute promyelocytic leukemia (APL) condition, which leads to an affected expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class6.2: STAT domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
STAT3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC35A5 gene in glioblastoma multiforme condition | [13] | ||||
TF Protein Name |
Signal transducer and activator of transcription 3 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Signal transducer and activator of transcription 3 (STAT3) has been reported to bind to the transcription of SLC35A5 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC35A5 gene in megakaryocytes condition | [11] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC35A5 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC35A5 gene | [3] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC35A5 gene, which in turn affects the expression or function of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC35A5 gene in epithelial ovarian cancer condition | [14] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SLC35A5 gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Probable UDP-sugar transporter protein SLC35A5. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.